Influence of phenobarbital on morphine metabolism and disposition: LC-MS/MS determination of morphine (M) and morphine-3-glucuronide (M3G) in Wistar-Kyoto rat serum, bile, and urine

Current Drug Metabolism

Volumn 8, Issue 1, 2007, Pages 79-89

  Alnouti, Yazen M ^a   Shelby, Melinda K ^a   Chen, Chuan ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

CAR; HPLC; Induction; Mass spectrometry; Morphine; Morphine glucuronide; Phenobarbital; UGT; Wistar Kyoto rats

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; MORPHINE; MORPHINE 3 GLUCURONIDE; PHENOBARBITAL;

ACCURACY; ANIMAL CELL; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SOLID PHASE EXTRACTION; VALIDATION PROCESS; WISTAR KYOTO RAT;

ANIMALS; BILE; FEMALE; MALE; MORPHINE; MORPHINE DERIVATIVES; PHENOBARBITAL; RATS; RATS, INBRED WKY;

EID: 33846004452     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920007779315026     Document Type: Review

References (55)

1. Christrup, L.L. (1997) Morphine metabolites. Acta Anaesthesiol. Scand. 41(1 Pt 2), 116-122.
2. Yeh, S.Y.; Gorodetzky, C.W. and Krebs, H.A. (1977) J. Pharm. Sci. 66(9), 1288-1293.
3. Oguri, K.; Ida, S.; Yoshimura, H. and Tsukamoto, H. (1970) Chem. Pharm. Bull. (Tokyo) 18(12), 2414-2419.
4. Anderson, G.; Christrup, L.; Per, S. (2003) J. Pain Symptom. Manage 25(1), 74-91.
5. Shimomura, K.; Kamata, O.; Ueki, S.; Ida, S. and Oguri, K. (1971) Tohoku. J. Exp. Med. 105(1), 45-52.
6. Smith, M.T.; Watt, J.A. and Cramond, T. (1990) Life Sci. 47(6), 579-585.
7. Skarke, C.; Geisslinger, G.; Lotsch, J. (2005) Pain 116(3), 177-180.
8. Coughtrie, M.W.; Ask, B.; Rane, A.; Burchell, B. and Hume, R. (1989) Biochem. Pharmacol. 38(19), 3273-3280.
9. Toyooka, T.; Yano, M.; Kato, M.; Nakahara, Y. (2001) Analyst 126(8), 1339-45.
10. Kikura-Hanajiri, R.; Kaniwa, N.; Ishibashi, M.; Makino, Y.; Kojima, S. (2003) J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 789(1), 139-50.
11. Van Crugten, J.T.; Somogyi, A.A.; Nation, R.L.; Reynolds, G. (1997) Pain 71(2), 199-205.
12. Kuo, C.K.; Hanioka, N.; Noshikawa, Y.; Oguri, K.; Yoshimura, H. (1991) J. Pharmacobiodyn. 14(4), 187-93.
13. Salem, A.; Hope, W. 1997 Pharmacol. Biochem. Behav. 57(4), 801-7.
14. Milne, R.W.; Nation, R.L; Somogyi, A.A. 1996 Drug Metab. Rev. 28(3), 345-472.
15. Sarton, E.; Olofsen, E.; Romberg, R.; den Hartigh, J.; Kest, B.; Nieuwenhuijs, D.; Burm, A.; Teppema, L. and Dahan, A. (2000) Anesthesiology 93(5), 1245-1254.
16. Romero, M.T.; Kepler, K.L. and Bodnar, R.J. (1988) Pharmacol. Biochem. Behav. 29(4), 705-709.
17. Candido, J.; Lutfy, K.; Billings, B.; Sierra, V.; Duttaroy, A.; Inturrisi, C.E. and Yoburn, B.C. (1992) Pharmacol. Biochem. Behav. 42(4), 685-692.
18. Gordon, N.C.; Gear, R.W.; Heller, P.H.; Paul, S.; Miaskowski, C.; Levine, J.D. (1995) Neuroscience 69(2), 345-349.
19. Baker, L. and Ratka, A. (2002) Pain 95(1-2), 65-74.
20. Shelby, M.K.; Cherrington, N.J.; Vansell, N.R. and Klaassen, C.D. (2003) Drug Metab. Dispos. 31(3), 326-333.
21. Shelby, M.K.; Klaassen, C.D. (2006) Drug Metab. Dispos. [Epub ahead of print].
22. Wei, P.; Zhang, J.; Egan-Hafley, M.; Liang, S. and Moore, D.D. (2000) Nature 407(6806), 920-923.
23. Yoshinari, K.; Sueyoshi, T.; Moore, R. and Negishi, M. (2001) Mol. Pharmacol. 59(2), 278-284.
24. Cherrington, N.J.; Slitt A.L.; Maher, J.M.; Zhang, X.X.; Zhang, J.; Huang, W.; Wan Y.J.; Moore, D.D.; Klaassen, C.D. (2003) Drug Metab. Dispos. 31(11), 1315-19.
25. Bourquin, D.; Lehmann, T.; Hammig, R.; Buhrer, M. and Brenneisen, R. (1997) J. Chromatogr. B. Biomed. Sci. Appl. 694(1), 233-238.
26. Beike, J.; Kohler, H.; Brinkmann B and Blaschke G (1999) J. Chromatogr. B. Biomed. Sci. Appl. 726(1-2), 111-119.
27. Ary, K. and Rona, K. (2001) J. Pharm. Biomed. Anal. 26(2), 179-187.
28. Hupka, Y.; Beike, J.; Roegener, J.; Brinkmann, B.; Blaschke, G. and Kohler, H. (2005) Int. J. Legal. Med. 119(3), 121-128.
29. Meng, Q.C.; Cepeda, M.S.; Kramer, T.; Zou, H.; Matoka, D.J. and Farrar, J. (2000) J. Chromatogr. B. Biomed. Sci. Appl. 742(1), 115-123.
30. Evans, A.M.; O'Brien, J. and Nation, R.L. (1999) J. Pharm. Pharmacol. 51(11), 1289-1297.
31. Wright, A.W. and Smith, M.T. (1998) Ther. Drug. Monit. 20(2), 215-218.
32. Chapman, D.J.; Cross, M.J.; Joel, S.P. and Aherne, G.W. (1995) Ann. Clin. Biochem. 32(Pt 3), 297-302.
33. Schuberth, J. (1989) J. Chromatogr. 490(2), 444-449.
34. Tagliaro, F.; Poiesi, C.; Aiello, R.; Dorizzi, R.; Ghielmi, S. and Marigo, M. (1993) J. Chromatogr. 638(2), 303-309.
35. Wernly, P.; Thormann, W.; Bourquin, D. and Brenneisen, R. (1993) J. Chromatogr. 616(2), 305-310.
36. Jemal, M. (2000) Biomed Chromatogr. 14(6), 422-429.
37. Murphy, C.M.; Huestis, M.A. (2006) J. Mass Spectrom. 40(11), 1412-6.
38. Schanzle, G.; Li, S.; Mikus, G. and Hofmann, U. (1999) J. Chromatogr. B. Biomed. Sci. Appl. 721(1), 55-65.
39. Musshoff, F.; Lachenmeier, K.; Wollersen, H.; Lichtermann, D.; Madea, B. (2005) J. Anal. Toxicol. 29(5), 345-52.
40. Bengtsson, J.; Jansson, B.; Hammarlund-Udenas, M. (2005) Rapid Commun. Mass Spectrom. 19(15), 2116-22.
41. Blanchet, M.; Bru G.; Guerret, M.; Bromet-Petit, M. and Bromet, N. (1999) J. Chromatogr. A 854(1-2), 93-108.
42. Naidong, W.; Lee, J.W.; Jiang, X.; Wehling, M.; Hulse, J.D. and Lin, P.P. (1999) J. Chromatogr. B. Biomed. Sci. Appl. 735(2), 255-269.
43. Shou, W.Z.; Pelzer, M.; Addison, T.; Jiang, X. and Naidong, W. (2002) J. Pharm. Biomed. Anal. 27(1-2), 143-152.
44. Whittington, D. and Kharasch, E.D. (2003) J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 796(1), 95-103.
45. Slawson, M.H.; Crouch, D.J.; Andrenyak, D.M.; Rollins, D.E.; Lu, J.K.; Baily, P.L. 1999 J. Anal. Toxicol. 23(6), 468-473.
46. Pichini, S.; Pacifici, R.; Pellegrini, M.; Marchei, E.; Perez-Alarcon, E.; Puig, C.; Vall, O. and Garcia-Algar, O. (2003) J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 794(2), 281-292.
47. Mabuchi, M.; Takatsuka, S.; Matsuoka, M. and Tagawa, K. (2004) J. Pharm. Biomed. Anal. 35(3), 563-573.
48. Edwards, S.R. and Smith, M.T. (2005) J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci 814(2), 241-249.
49. Projean, D.; Minh Tu, T. and Ducharme, J. (2003) J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 787(2), 243-253.
50. Zheng, M.; McErlane, K.M. and Ong, M.C. (1998) J. Pharm. Biomed. Anal. 16(6), 971-980.
51. Stain-Texier, F.; Sandouk, P.; Schermann, J-M. (1998) Drug Metab. Disp. 26(5), 383-387.
52. Milne, R.W.; Jensen, R.H.; Larsen, C.; Evans, A.M.; Nation, R.L. (1997) Pharm. Res. 14(8), 1014-18.
53. King, R.; Bonfiglio, R.; Fernandez-Metzler, C.; Miller-Stein, C. and Olah, T. (2000) J. Am. Soc. Mass. Spectrom 11(11), 942-950.
54. Karch, S.B. (2002) Karch's Pathology Drug Abuse; 3rd ed. Boca Raton; Florida: CRC Press.
55. Klaassen, C.D. (2001) Casarett and Doull's Toxicology The Basic Science of Poisons; 6th ed. New York: McGraw-Hill.